Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Alzheimer's Disease

  Free Subscription


06.06.2022

3 Alzheimer Dis Assoc Disord
1 Alzheimers Dement
1 Am J Geriatr Psychiatry
2 BMC Geriatr
1 BMC Neurol
1 Exp Gerontol
1 Int J Neurosci
1 J Alzheimers Dis
1 J Biol Chem
1 J Neurol
2 J Neurol Neurosurg Psychiatry
1 Lancet Neurol
1 Nat Rev Neurol
1 Nature
3 Neurobiol Aging
2 Neurology
1 Neuroscience


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Alzheimer Dis Assoc Disord

  1. ASTOLFI NEVES B, Villela Nunes P, Diehl Rodriguez R, Medeiros Haidar A, et al
    Cause of Death Determined by Full-body Autopsy in Neuropathologically Diagnosed Dementias: The Biobank for Aging Studies of the University of Sao Paulo (BAS-USP), Brazil.
    Alzheimer Dis Assoc Disord. 2022;36:156-161.
    PubMed         Abstract available

  2. STREITZ ML, Denny A, Xiong C, McCue L, et al
    Development of a Comprehensive Battery to Collect Social and Structural Determinants of Health (SSDOH) in Cognitively Normal or Very Mildly Impaired Persons.
    Alzheimer Dis Assoc Disord. 2022;36:97-102.
    PubMed         Abstract available

  3. DOHERTY T, Gee M, Maruff P, Smith R, et al
    Increasing the Cognitive Screening Efficiency of Global Phase III Trials in Early Alzheimer Disease: The Cognitive Task Force.
    Alzheimer Dis Assoc Disord. 2022 May 10. pii: 00002093-990000000-00007.
    PubMed         Abstract available


    Alzheimers Dement

  4. GUSTAVSSON A, Norton N, Fast T, Frolich L, et al
    Global estimates on the number of persons across the Alzheimer's disease continuum.
    Alzheimers Dement. 2022 Jun 2. doi: 10.1002/alz.12694.
    PubMed         Abstract available


    Am J Geriatr Psychiatry

  5. FISCHER CE
    Commentary on Agitation in Cognitive Disorders: Use of the National Alzheimer's Coordinating Center Uniform Data Set (NACC-UDS) to Evaluate International Psychogeriatric Association Definition.
    Am J Geriatr Psychiatry. 2022 May 5. pii: S1064-7481(22)00403.
    PubMed        


    BMC Geriatr

  6. WEI M, Ni J, Shi J, Li T, et al
    Plasma repressor element 1-silencing transcription factor levels are decreased in patients with Alzheimer's disease.
    BMC Geriatr. 2022;22:471.
    PubMed         Abstract available

  7. ALI BABAR B, Vu M, Koponen M, Taipale H, et al
    Prevalence of oral anticoagulant use among people with and without Alzheimer's disease.
    BMC Geriatr. 2022;22:464.
    PubMed         Abstract available


    BMC Neurol

  8. XIA P, Chen J, Bai X, Li M, et al
    Key gene network related to primary ciliary dyskinesia in hippocampus of patients with Alzheimer's disease revealed by weighted gene co-expression network analysis.
    BMC Neurol. 2022;22:198.
    PubMed         Abstract available


    Exp Gerontol

  9. AKUSHEVICH I, Yashkin AP, Kravchenko J, Kertai MD, et al
    Extended anesthesia exposure for abdominal and pelvic procedures in older adults with colorectal cancer: Associations with chart dementia diagnoses.
    Exp Gerontol. 2022;164:111830.
    PubMed         Abstract available


    Int J Neurosci

  10. BATAWI AH
    Ginkgo biloba extract mitigates the neurotoxicity of AlCl3 in Alzheimer rat's model: Role of Apolipoprotein E4 and clusterin genes in stimulating ROS generation and apoptosis.
    Int J Neurosci. 2022 May 30:1-16. doi: 10.1080/00207454.2022.2082968.
    PubMed         Abstract available


    J Alzheimers Dis

  11. MCGRATTAN A, Stewart CJ, Cassidy A, Woodside JV, et al
    Diet Patterns, the Gut Microbiome, and Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 23. pii: JAD220205. doi: 10.3233/JAD-220205.
    PubMed         Abstract available


    J Biol Chem

  12. LIANG R, Tian Y, Viles JH
    Cross-seeding of wild-type Amyloid-beta with Arctic but not Italian familial mutants accelerates fibril formation in Alzheimer's Disease.
    J Biol Chem. 2022 May 25:102071. doi: 10.1016/j.jbc.2022.102071.
    PubMed         Abstract available


    J Neurol

  13. CLARK E, Faruque S, Mutebi C, Nagirimadugu NV, et al
    Investigating the relationship between mild traumatic brain injury and Alzheimer's disease and related dementias: a systematic review.
    J Neurol. 2022 Jun 1. pii: 10.1007/s00415-022-11186.
    PubMed         Abstract available


    J Neurol Neurosurg Psychiatry

  14. OVERMAN MJ, Drummond N, Butler CR, Ahmed S, et al
    Tracking the clinical progression of posterior cortical atrophy: implications for post-diagnostic and therapeutic interventions.
    J Neurol Neurosurg Psychiatry. 2022;93:683-684.
    PubMed        

  15. PARNETTI L, Paolini Paoletti F, Gaetani L
    Blood biomarkers may distinguish among dementia disorders.
    J Neurol Neurosurg Psychiatry. 2022;93:571.
    PubMed        


    Lancet Neurol

  16. OSSENKOPPELE R, van der Kant R, Hansson O
    Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials.
    Lancet Neurol. 2022 May 25. pii: S1474-4422(22)00168.
    PubMed         Abstract available


    Nat Rev Neurol

  17. LILL CM, Bertram L
    Genome-wide analysis furthers decoding of Alzheimer disease genetics.
    Nat Rev Neurol. 2022 May 27. pii: 10.1038/s41582-022-00678.
    PubMed        


    Nature

  18. KARLAWISH J
    Fix the process that led to Alzheimer's drug fiasco.
    Nature. 2022;606:9.
    PubMed        


    Neurobiol Aging

  19. ZHOU XA, Ngiam G, Qian L, Sankorrakul K, et al
    The basal forebrain volume reduction detected by MRI does not necessarily link with the cholinergic neuronal loss in the Alzheimer's disease mouse model.
    Neurobiol Aging. 2022;117:24-32.
    PubMed         Abstract available

  20. DONG R, Denier-Fields DN, Lu Q, Suridjan I, et al
    Principal components from untargeted cerebrospinal fluid metabolomics associated with Alzheimer's disease biomarkers.
    Neurobiol Aging. 2022;117:12-23.
    PubMed         Abstract available

  21. QUINTAS-NEVES M, Teylan MA, Morais-Ribeiro R, Almeida F, et al
    Divergent magnetic resonance imaging atrophy patterns in Alzheimer's disease and primary age-related tauopathy.
    Neurobiol Aging. 2022;117:1-11.
    PubMed         Abstract available


    Neurology

  22. KUMAR A, Janelidze S, Stomrud E, Palmqvist S, et al
    beta-Amyloid-Dependent and -Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease.
    Neurology. 2022 May 31. pii: WNL.0000000000200605.
    PubMed         Abstract available

  23. JOSEPHS KA, Weigand SD, Whitwell J
    Characterizing Amyloid Positive Individuals With Normal Tau PET Levels After 5 Years: An ADNI Study.
    Neurology. 2022 Mar 21. pii: WNL.0000000000200287.
    PubMed         Abstract available


    Neuroscience

  24. GUZMAN-RAMOS K, Osorio-Gomez D, Bermudez-Rattoni F
    Cognitive impairment in alzheimer's and metabolic diseases: A catecholaminergic hypothesis.
    Neuroscience. 2022 May 30. pii: S0306-4522(22)00271.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: